A new manuscript from the IGNITE Pragmatic Trials Network has been published in JAMA Network Open, describing the primary results of the GUARDD-US study. GUARDD-US is a randomized controlled trial examining the impact of returning APOL1 genetic risk results to ...
Updates in Precision Medicine: Pharmacogenomics and Pharmacovigilance Conference Wednesday, September 28 – Thursday, September 29, 2022 | Orlando, FL & Online This conference, co-hosted by the University of Florida College of Pharmacy and GenomeWeb's Precision Medicine Leaders’ Summit, will highlight the evolving role of molecular profiling in pharmacology – from new developments in pharmacogenomics to […]
Thursday, September 29 | 9 am EST | Virtual This webinar will be presented by Dr. Nahla Maher Afifi. The title of her talk is “Qatar Biobank: A Pillar in Precision Medicine Initiative.” To learn more about the guest speaker and webinar, please visit the IHCC Educational Webinar Series webpage. Please note: Registration is required for […]
From All of Us Research to All of Us in the Real World: Using the All of Us Research Program Data to Improve Population Health Thursday, September 29 | 9:30-11 a.m., ET | Virtual | Free, registration required Through a Data Use Agreement with the All of Us Research Program, scientists at the Centers for […]
Wednesday, October 12, 2022 | 10:30 am - 6 pm ET | Virtual A planning committee of the National Academies of Sciences, Engineering, and Medicine will organize and conduct a public workshop to examine how genomic data are used in health care settings and to identify opportunities for advancement of precision health care delivery. The […]
GMKB